Works matching Myelodysplastic syndromes and cancer

Results: 288
    1
    2

    A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 4, p. 760, doi. 10.3109/10428194.2012.737917
    By:
    • Macdonald, David A.;
    • Assouline, Sarit E.;
    • Brandwein, Joseph;
    • Kamel-Reid, Suzanne;
    • Eisenhauer, Elizabeth A.;
    • Couban, Stephen;
    • Caplan, Stephen;
    • Foo, Alison;
    • Walsh, Wendy;
    • Leber, Brian
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study.

    Published in:
    Leukemia & Lymphoma, 2010, v. 51, n. 2, p. 252, doi. 10.3109/10428190903585286
    By:
    • Crump, Michael;
    • Hedley, David;
    • Kamel-Reid, Suzanne;
    • Leber, Brian;
    • Wells, Richard;
    • Brandwein, Joseph;
    • Buckstein, Rena;
    • Kassis, Janine;
    • Minden, Mark;
    • Matthews, John;
    • Robinson, Sue;
    • Turner, Robert;
    • Mcintosh, Lynn;
    • Eisenhauer, Elizabeth;
    • Seymour, Lesley
    Publication type:
    Article
    21
    22
    23
    24
    25

    PB1844: REAL: A RETROSPECTIVE STUDY OF THE CLINICO‐BIOLOGICAL FEATURES OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS INCLUDED IN AN EARLY PHASE TRIAL AT A COMPREHENSIVE CANCER CENTER.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000974216.45201.63
    By:
    • Berton, Guillaume;
    • Vicier, Cécile;
    • Hospital, Marie‐Anne;
    • Saillard, Colombe;
    • Hicheri, Yosr;
    • Maisano, Valerio;
    • Villetard, Ferdinand;
    • Rouzaud, Camille;
    • Corda, Evelyne D’incan;
    • Rey, Jerome;
    • Mohty, Bilal;
    • Charbonnier, Aude;
    • Proux, Aurelien;
    • Vey, Norbert;
    • Goncalves, Anthony;
    • Garciaz, Sylvain
    Publication type:
    Article
    26
    27
    28
    29
    30
    31

    Cancer testis antigens in myelodysplastic syndromes revisited: a targeted RNA-seq approach.

    Published in:
    OncoImmunology, 2020, v. 9, n. 1, p. 1, doi. 10.1080/2162402X.2020.1824642
    By:
    • Hurtado López, Ana María;
    • Chen-Liang, Tzu Hua;
    • Zurdo, María;
    • Carrillo-Tornel, Salvador;
    • Panadero, Joaquín;
    • Salido, Eduardo José;
    • Beltrán, Victor;
    • Muiña, Begoña;
    • Amigo, MariLuz;
    • Navarro-Villamor, Noelia;
    • Cifuentes, Rosa;
    • Calabria, Inés;
    • Antón, Ana Isabel;
    • Teruel, Raúl;
    • Muro, Manuel;
    • Vicente, Vicente;
    • Jerez, Andrés
    Publication type:
    Article
    32
    33
    34
    35

    Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).

    Published in:
    Breast Cancer Research & Treatment, 2017, v. 161, n. 2, p. 363, doi. 10.1007/s10549-016-4051-1
    By:
    • Freedman, Rachel;
    • Seisler, D.;
    • Foster, J.;
    • Sloan, J.;
    • Lafky, J.;
    • Kimmick, G.;
    • Hurria, A.;
    • Cohen, H.;
    • Winer, E.;
    • Hudis, C.;
    • Partridge, A.;
    • Carey, L.;
    • Jatoi, A.;
    • Klepin, H.;
    • Citron, M.;
    • Berry, D.;
    • Shulman, L.;
    • Buzdar, A.;
    • Suman, V.;
    • Muss, H.
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trial.

    Published in:
    Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 433, doi. 10.1007/s00262-021-02993-6
    By:
    • Holmberg-Thydén, Staffan;
    • Dufva, Inge Høgh;
    • Gang, Anne Ortved;
    • Breinholt, Marie Fredslund;
    • Schejbel, Lone;
    • Andersen, Mette Klarskov;
    • Kadivar, Mohammad;
    • Svane, Inge Marie;
    • Grønbæk, Kirsten;
    • Hadrup, Sine Reker;
    • El Fassi, Daniel
    Publication type:
    Article
    45
    46
    47

    Triple primary malignancies of surface osteosarcoma of jaw, myelodysplastic syndrome and colorectal cancer as a second primary cancer detected by PET2‑[<sup>18</sup>F]‑fluoro‑2‑deoxy‑D‑glucose positron emission tomography: A case report.

    Published in:
    Oncology Letters, 2018, v. 15, n. 6, p. 9901, doi. 10.3892/ol.2018.8594
    By:
    • Maruyama, Nobuyuki;
    • Nishihara, Kazuhide;
    • Nakasone, Toshiyuki;
    • Saio, Masanao;
    • Maruyama, Tessho;
    • Tedokon, Iori;
    • Ohira, Tetsuya;
    • Nimura, Fumikazu;
    • Matayoshi, Akira;
    • Karube, KEN-Nosuke;
    • Yoshimi, Naoki;
    • Arasaki, Akira
    Publication type:
    Article
    48
    49
    50